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The isoforms present ina crude preparation f bovine neutrophil protein kinase (PKC) were identified by immunodetection with antibodies directed 
against specific sequences of bovine and rat brain PKC isozymes. The major isoform of bovine neutrophil PKC was identified as fl-PKC and the 
minor one as (-PKC. 
Protein kinase C; Isoform; Neutrophil 
1. INTRODUCTION 
Cloning and sequence analysis of cDNA encoding 
protein kinase C (PKC) have established the molecular 
diversity of this enzyme family. In fact, PKC consists of 
several subspecies with a high degree of homology. In- 
itially, the presence of three PKC subspecies designated 
as c~, 3 (3I plus 311) and y, was deduced from the se- 
quence of cloned cDNAs obtained from bovine, rat, 
rabbit and human brain, and later human spleen cDNA 
libraries. More recently, three additional members of 
this family, termed 5, e and ~', have been identified, 
which lack one of the four conserved regions found in 
the first three mentioned subspecies [1]. Different 
cellular localizations have been found for the PKC 
subspecies, suggesting specific functions for each 
subspecies in the cell economy [2]. A purified prepara- 
tion of PKC was recently isolated from bovine 
neutrophils in which the enzyme is abundant [3]. Its 
PKC isozyme pattern was, in a first approach, deduced 
from the profile of elution from an hydroxyapatite 
(HTP) column by a gradient of potassium phosphate 
and from the nature of the phosphorylated amino acid 
residues in autophosphorylated PKC. Compared to 
bovine brain PKC, whose activity was recovered from 
HTP in 3 main peaks, termed I, II and III in the order 
of elution, corresponding to the y-, 3- and a-isoforms, 
bovine neutrophil PKC was eluted in a single peak 
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located in the phosphate gradient at the same position 
as peak I of bovine brain PKC. On the other hand, 
autophosphorylation of bovine neutrophil PKC in the 
presence of [y-32p]ATP, MgClz, CaC12, phos- 
phatidylserine and diacylglycerol resulted in the labell- 
ing of serine and threonine residues, which was typical 
of the 3-isoform of PKC [4]. This discrepancy war- 
ranted a direct determination of the isotype pattern of 
bovine neutrophil PKC by an immunochemical p- 
proach. In this report, we demonstrate hrough the use 
of antipeptide antibodies directed against he c~-, 3-, 5-, 
e- and g'-isoforms of brain PKC that bovine neutrophil 
PKC exists as two isoenzymes, namely 3-PKC and 
~'-PKC. 
2. MATERIALS AND METHODS 
2.1. Chemicals 
The following materials were supplied by the companies indicated: 
[1251]Protein A and [y)ZP]ATP, Amersham; nitrocellulose BA83, 
Schleicher and Schuell; acrylamide and bis(acrylamide), BDH; DE52 
cellulose, Whatman; hydroxylapatite HPLC column (10 × 0.76 cm), 
Mitsui Toatso Chemicals (Tokyo); MonoQ column (HR 5/5), phenyl- 
Sepharose CL-4B, Percoll and molecular weight markers, Pharmacia- 
LKB; all other chemicals, Sigma. Extract from COS-7 transfected 
with PKC-g'-cDNA was kindly provided by J. Knopf and Ron Kritz 
(Genetics Institute, Cambridge, MA, USA). 
2.2. Purification of bovine neutrophil PKC, and rat and bovine brain 
PKC 
Bovine neutrophil PKC was purified to homogeneity [3], all steps 
being conducted at 2-4°C. Briefly, 5 × 109-10 l° neutrophils obtained 
from 10 liters of fresh cow's blood were disrupted by sonication i a 
medium consisting of 0.25 M sucrose, 10 mM Mops, pH 7.4, 2 mM 
EGTA, 10 mM EDTA, 50 mM 3-mercaptoethanol, 1 mM PMSF, 1 
/~g/ml TPCK, 1 #g/ml TLCK, 1 #g/ml soybean trypsin inhibitor and 
10/~g/ml leupeptin. The supernatant recovered after 1 h of centrifuga- 
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tion at 150 000 × g in a Ti 45 rotor (Beckman) was loaded onto a DE52 
cellulose column and a linear 0-0.3 M NaCI gradient was applied. Ac- 
tive fractions eluted between 0.08 and 0.12 M NaCI were desalted and 
chromatographed on a MonoQ column in an FPLC system. Two 
peaks of PKC activity, both Ca 2+ and phospholipid dependent, were 
recovered with 0.05 M NaC1 (peak 1) and 0.12 M NaCI (peak 2), 
respectively. The material of peak 2 from the MonoQ could be readily 
purified to homogeneity b  phenyl-Sepharose chromatography. The 
phenyl-Sapharose column was eluted with a decreasing linear (1.5-0 
M) gradient NaC1 and the active fractions were recovered at low salt 
concentration. Purified PKC was stored in 0.05% Tween 20. PKC ac- 
tive fractions were dialysed overnight against 10 mM phosphate, pH 
7.5, 15% glycerol, 10 mM/3-mercaptoethanol, 0.05% Tween 20 prior 
to chromatography on HTP. 
Rat brain PKC and bovine brain PKC were purified as described in
[5] and [3], respectively. Brains were homogenized with a Potter- 
Elvejhem homogenizer in the same buffer as for bovine neutrophils. 
The supernatant recovered after a 60 rain centrifugation at 
100 000×g was loaded onto a DE52 column and a linear (0-0.4 M 
NaC1) gradient was applied. Active PKC fractions were eluted with 
about 0.08 M NaC1 and pooled. Powdered ammonium sulfate was 
added to 80% saturation. After 4 h at 2-4°C, the precipitate was col- 
lected by centrifugation. The pellet was solubilized in 4 ml of a 
medium containing 20 mM Tris, pH 7.5, 2 mM EDTA, 2 mM EGTA, 
2 mM DTT and 2% glycerol. The next wo steps were gel filtration on 
AcA 44, followed by chromatography on phenyl-Sepharose similar to 
that used for bovine neutrophil PKC purification. The active frac- 
tions were pooled and ialysed overnight against 10 mM phosphate, 
pH 7.5, 15% glycerol and 1 mM DTT prior to HTP chromatography. 
2.3. Separation of PKC isoforms from bovine neutrophils and rat or 
bovine brains by HTP chromatography 
The enzyme solution was applied to an HTP column (10 x 0.76 cm). 
Elution was carried out with a concave 0.010-0.175 M potassium 
phosphate gradient, pH 7.4, programmed in an HPLC system [3,5]. 
The three main isoforms, numbered I, II and II1 according to the 
order of elution from HTP corresponded to the 7-,/3- and u-PKC 
gene products, respectively. 
2.4. Assay of PKC activity 
PKC activity was measured by enzymatic transfer of the terminal 
radiolabeled phosphate from [7-32P]ATP to histone type IllS [6]. 
2.5. Western blot 
PKC partially purified at the stage of the MonoQ chromatography 
was subjected to SDS-PAGE using a 8% acrylamide gel. The proteins 
were transferred onto a nitrocellulose membrane [7,8]. Non-specific 
sites were blocked by incubating the membrane with 5 % instant milk 
(Carnation, USA) and 0.5% Tween 20 for 1 h at 41°C. The im- 
munoreaction complex was detected with [lzSI]protein A (Amersham) 
(0.1 #Ci/ml) exactly as described [9,10]. The nitrocellulose membrane 
was exposed to Kodak XA5 film with intensifying screens at -70°C 
overnight for/3-PKC and two days for all other isoenzymes. 
2.6. Synthesis of peptide and preparation of antipeptide antibodies 
Peptides representing selected amino acid clusters of PKC were 
prepared from the cDNA sequences related to different PKC isoen- 
zymes from bovine brain. They were coupled either to keyhole limpet 
hemocyanin [10] or to tuberculin PPD [11], and injected into rabbits. 
The specificity of the antisera was previously documented [9,11]. 
Another set of peptides corresponding to selected sequences of c~-,/3- 
and 7-PKC isoform from rat brain was prepared and coupled to BSA 
before injection into rabbits (Pelosin et al., unpublished). 
3. RESULTS 
The isoforms of bovine neutrophil PKC and bovine 
brain PKC were resolved in parallel by HTP 
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Fig. 1. Separation of bovine and neutrophil PKC isoforms by HTP 
chromatography. PKC-containing fractions eluted from phenyl- 
Sepharose column were loaded on HTP column. The column was 
eluted with a linear gradient (0.010-0.175 M) of potassium 
phosphate. Fig. 1 represents he HTP elution profile of purified 
bovine neutrophil PKC. The inset represents the HTP elution profile 
of purified bovine brain PKC. PKC activity was measured in the 
presence of 1 mM CaClz, 20 #g/ml phosphatidylserine, 2 #g/ml 
diolein as described in [3]. No kinase activity was detected in the 
absence of 1 mM Ca 2 +, 20 t~g/ml phosphatidylserine, 2/zg/ml diolein 
and in the presence of 1 mM EGTA. 
chromatography using a linear 0.01-0.175 M gadient of 
potassium phosphate, pH 7.4, 15% glycerol, 1 mM 
DTT [3]. The elution profiles are illustrated in Fig. 1. 
Bovine neutrophil PKC was eluted in a single peak with 
0.03 M potassium phosphate, i.e. with the same 
phosphate concentration as that required for the elution 
of peak I of bovine brain PKC corresponding to the 7- 
subspecies. The same pattern of elution was obtained 
with enzyme preparations at earlier stages of the 
purification procedure. 
The PKC isoforms of bovine neutrophils were 
analyzed by immunoblotting experiments, using 
polyclonal antipeptide antibodies. In the case of the 
isoforms a, (3 and 7, two series of antibodies were used, 
which were obtained against peptides chosen in one of 
the five variable domains of bovine brain and rat brain 
PKC referred to as V3, whose accessibility is ascertain- 
ed by its ready attack by calpain [12]. For the c5-, 3'- and 
~'-isoforms, the antibodies were generated from pep- 
tides corresponding to specific sequences of bovine 
brain PKC. 
In the case of bovine brain PKC, 6 peptides were syn- 
thesized, which corresponded to the following residues: 
318-331 (ISPSEDRRQPSNNL) for o~-PKC [9], 
319-332 (EKTTNTISKFDNNG) for ~-PKC [9], 
316-332 (VRTGPSSSPIPSPSPT) for 7-PKC [9], 
318-334 (KTAVSGNDIPDNNGTYG) for ~-PKC 
[10,11], 836-853 (NQEEFKGFSYFGEDLMP)for e- 
PKC [10,11] and 128-142 (SEDLKPVIDGDDGIK)for 
~'-PKC [10,11]. Each antipeptide antibody reacted effi- 
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Fig. 2. Immunoreactivity of neutrophil PKC isoforms with antipeptide antibodies directed against c~-, ~-, 7-, E-, ~5- and ~'-PKC. (A) PKC from 
bovine neutrophils (PMN) purified by MonoQ chromatography wassubjected to8o7o SDS-PAGE and electrotransferred onto a nitrocellulose heet. 
The transferred PKC bands were detected with antisera directed against ~-PKC (sequence 318-331),/3-PKC (sequence 319-332), 3 -PKC (sequence 
316-332) and specific sequences from e-, (5- and g-PKC as described insections 2 and 3. Positive controls were obtained using purified c~-PKC and 
/3-PKC from rat brain, extracts from transfected CHO cells with cDNA derived from 3'- and e-sequences [9], extracts from COS-7 cells transfected 
with cDNA derived from ~'-sequences and brain extract from 5-isoform. (B) A parallel immunodetection experiment was performed with bovine 
neutrophil PKC recovered from phenyl-Sepharose andantibodies directed against the following sequences: c~-PKC (320-335),/3-PKC (319-335), 
3,-PKC (683-697). 
ciently with its own antigen [9-11]. Concerning the o~-, 
~- and ,y-isoforms of rat brain PKC, the peptides used 
corresponded to the following residues: 320-335 
(PSEDRKQPSLNLDR) for c~-PKC, 319-335 
(EKTALTISKFPNNGNR) for /3-PKC and the C- 
terminus peptide 683-697 (PDARSPTSPVPVPVM) 
for -y-PKC (Pelosin et al., unpublished). 
Western blot analysis of bovine neutrophil PKC par- 
tially purified by chromatography on MonoQ (Fig. 2A) 
or purified to homogeneity using phenyl-Sepharose 
chromatography (Fig. 2B) is shown in Fig. 2. Among 
the antibodies raised against chosen peptide sequences 
from bovine brain and rat brain, only those raised 
against sequences of ~-PKC and ~-PKC were found to 
be immunoreactive (Fig. 2A,B). 
4. DISCUSSION 
The immunochemical demonstration that one of the 
two isozymes of bovine neutrophil PKC is a /3- 
subspecies agrees with the conclusion drawn from the 
nature of the phosphorylated amino acid residues in 
autophosphorylated PKC [3,4]. The other PKC 
isozyme of bovine neutrophil reacts with the anti-~'- 
antiserum and is present in relatively low amounts as 
compared to the ~-isoenzyme. So far, the ~'-PKC 
isozyme has been identified in expression experiments 
using the corresponding specific cDNA [13]. Only 
recently, ~'-PKC was described in nuclei of nerve cells 
[14]. Bovine neutrophils are another example of cells 
where the ~'-isoform of PKC is expressed. 
The use of HTP chromatography as a means to 
resolve PKC isoforms deserves ome comment. In fact, 
bovine neutrophil PKC is eluted from the HTP as a 
single peak which coincides with that of the isoform I or 
3' of brain PKC. In the present immunochemical in- 
vestigation, using antibodies directed against wo dis- 
tant peptide sequences of the 7-isoform of brain PKC, 
no immunochemical reaction could be detected between 
bovine neutrophil PKC and the anti-PKC 3,-antibodies. 
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These results indicate that the HTP elution pattern of 
PKC cannot be used as a reliable criterion to 
characterize the PKC isozymes in a tissue extract. 
Like bovine neutrophils, human neutrophils contain 
a major 3-isoform of PKC; however, they differ from 
bovine neutrophils by the presence of a minor a- 
isoform of PKC and that of a Ca 2+, phospholipid 
dependent kinase not recognized by the antibodies 
against the ct-, 3- and 7-isotypes [15]. The presence of 
the ~'-isoform in human neutrophils has not been 
reported. In short, not only PKC isoforms have a dif- 
ferent issue distribution [16], but they appear to exhibit 
species pecificity for a given cell type. Yet the presence 
of a common subspecies, namely the 3-isoform, in both 
bovine and human neutrophils uggests that the 3- 
isoform may play a central role in specific functions of 
phagocytic cells. 
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